292 related articles for article (PubMed ID: 33615732)
1. Podocyte apoptosis in diabetic nephropathy by BASP1 activation of the p53 pathway via WT1.
Zhang Y; Xu C; Ye Q; Tong L; Jiang H; Zhu X; Huang L; Lin W; Fu H; Wang J; Persson PB; Lai EY; Mao J
Acta Physiol (Oxf); 2021 May; 232(1):e13634. PubMed ID: 33615732
[TBL] [Abstract][Full Text] [Related]
2. Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation.
Green LM; Wagner KJ; Campbell HA; Addison K; Roberts SG
Nucleic Acids Res; 2009 Feb; 37(2):431-40. PubMed ID: 19050011
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin3a promotes advanced diabetic nephropathy.
Aggarwal PK; Veron D; Thomas DB; Siegel D; Moeckel G; Kashgarian M; Tufro A
Diabetes; 2015 May; 64(5):1743-59. PubMed ID: 25475434
[TBL] [Abstract][Full Text] [Related]
4. BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1.
Carpenter B; Hill KJ; Charalambous M; Wagner KJ; Lahiri D; James DI; Andersen JS; Schumacher V; Royer-Pokora B; Mann M; Ward A; Roberts SG
Mol Cell Biol; 2004 Jan; 24(2):537-49. PubMed ID: 14701728
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of p53/miR-34a/SIRT1 axis ameliorates podocyte injury in diabetic nephropathy.
Liang Y; Liu H; Zhu J; Song N; Lu Z; Fang Y; Teng J; Dai Y; Ding X
Biochem Biophys Res Commun; 2021 Jun; 559():48-55. PubMed ID: 33932899
[TBL] [Abstract][Full Text] [Related]
6.
Liu X; Jiang L; Zeng H; Gao L; Guo S; Chen C; Liu X; Zhang M; Ma L; Li Y; Qi X; Wu Y
Autophagy; 2024 May; 20(5):1072-1097. PubMed ID: 38050963
[TBL] [Abstract][Full Text] [Related]
7. WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy.
Wan J; Hou X; Zhou Z; Geng J; Tian J; Bai X; Nie J
Free Radic Biol Med; 2017 Jul; 108():280-299. PubMed ID: 28315733
[TBL] [Abstract][Full Text] [Related]
8. Loss of PTEN promotes podocyte cytoskeletal rearrangement, aggravating diabetic nephropathy.
Lin J; Shi Y; Peng H; Shen X; Thomas S; Wang Y; Truong LD; Dryer SE; Hu Z; Xu J
J Pathol; 2015 May; 236(1):30-40. PubMed ID: 25641678
[TBL] [Abstract][Full Text] [Related]
9. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
10. The WT1-BASP1 complex is required to maintain the differentiated state of taste receptor cells.
Gao Y; Dutta Banik D; Muna MM; Roberts SG; Medler KF
Life Sci Alliance; 2019 Jun; 2(3):. PubMed ID: 31167803
[TBL] [Abstract][Full Text] [Related]
11. Albumin-induced apoptosis of tubular cells is modulated by BASP1.
Sanchez-Niño MD; Fernandez-Fernandez B; Perez-Gomez MV; Poveda J; Sanz AB; Cannata-Ortiz P; Ruiz-Ortega M; Egido J; Selgas R; Ortiz A
Cell Death Dis; 2015 Feb; 6(2):e1644. PubMed ID: 25675304
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of transcriptional coactivator YAP Impairs the expression and function of transcription factor WT1 in diabetic podocyte injury.
Chen J; Wang X; He Q; Yang HC; Fogo AB; Harris RC
Kidney Int; 2024 Jun; 105(6):1200-1211. PubMed ID: 38423183
[TBL] [Abstract][Full Text] [Related]
13. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
Gao J; Liang Z; Zhao F; Liu X; Ma N
Bioengineered; 2022 May; 13(5):12275-12288. PubMed ID: 35603354
[TBL] [Abstract][Full Text] [Related]
14. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
[No Abstract] [Full Text] [Related]
15. Podocyte-specific deletion of Rac1 leads to aggravation of renal injury in STZ-induced diabetic mice.
Ishizaka M; Gohda T; Takagi M; Omote K; Sonoda Y; Oliva Trejo JA; Asao R; Hidaka T; Asanuma K; Horikoshi S; Tomino Y
Biochem Biophys Res Commun; 2015 Nov; 467(3):549-55. PubMed ID: 26435502
[TBL] [Abstract][Full Text] [Related]
16. WT1 and its transcriptional cofactor BASP1 redirect the differentiation pathway of an established blood cell line.
Goodfellow SJ; Rebello MR; Toska E; Zeef LA; Rudd SG; Medler KF; Roberts SG
Biochem J; 2011 Apr; 435(1):113-25. PubMed ID: 21269271
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil and valsartan inhibit podocyte apoptosis in streptozotocin-induced diabetic rats.
Lv W; Zhang Y; Guan G; Li P; Wang J; Qi D
Pharmacology; 2013; 92(3-4):227-34. PubMed ID: 24158161
[TBL] [Abstract][Full Text] [Related]
18. BASP1 promotes apoptosis in diabetic nephropathy.
Sanchez-Niño MD; Sanz AB; Lorz C; Gnirke A; Rastaldi MP; Nair V; Egido J; Ruiz-Ortega M; Kretzler M; Ortiz A
J Am Soc Nephrol; 2010 Apr; 21(4):610-21. PubMed ID: 20110383
[TBL] [Abstract][Full Text] [Related]
19. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
[TBL] [Abstract][Full Text] [Related]
20. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
